American Journal of Clinical Dermatology

, Volume 18, Issue 4, pp 593–594 | Cite as

Comment on: Facial Hyperpigmentation in Skin of Color: Special Considerations and Treatment

Letter to the Editor

Notes

Compliance with Ethical Standards

Funding

No funding was received for the preparation of this letter.

Conflict of interest

Philip R. Cohen has no conflicts of interest directly relevant to the content of this letter.

References

  1. 1.
    Vashi NA, Wirya SA, Inyang M, Kundu RV. Facial hyperpigmentation in skin of color: special considerations and treatment. Am J Clin Dermatol. 2017;18:215–30.CrossRefPubMedGoogle Scholar
  2. 2.
    Lee A-Y. Recent progress in melasma pathogenesis. Pigm Cell Melanoma Res. 2015;28:648–60.CrossRefGoogle Scholar
  3. 3.
    Ogita A, Funasaka Y, Ansai S, Kawana S, Saeki H. Melasma in a male patient due to estrogen therapy for prostate cancer. Ann Dermatol. 2015;27:763–4.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Snyder A, Schiechert RA, Zaiac MN. Melasma associated with topical estrogen cream. J Clin Aesthet Dermatol. 2017;10(2):57–8.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Kim NH, Cheong KA, Lee TR, Lee AY. PDZK1 upregulation in estrogen-related hyperpigmentation in melasma. J Invest Dermatol. 2012;132:2622–31.CrossRefPubMedGoogle Scholar
  6. 6.
    Jang YH, Lee JY, Kang HY, Lee ES, Kim YC. Oestrogen and progesterone receptor expression in melasma: an immunohistochemical analysis. J Eur Acad Dermatol Venereol. 2010;24:1312–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. J Dermatol Sci. 2007;46:111–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Na JI, Choi SY, Yang SH, Choi HR, Kang HY, Park KC. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. J Eur Acad Dermatol Venereol. 2013;27:1035–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Sofen B, Prado G, Emer J. Melasma and post inflammatory hyperpigmentation: management update and expert opinion. Skin Ther Lett. 2016;21(1):1–7.Google Scholar
  10. 10.
    Rivas S, Pandya AG. Treatment of melasma with topical agents, peels and lasers: an evidence-based review. Am J Clin Dermatol. 2013;14:359–76.CrossRefPubMedGoogle Scholar
  11. 11.
    Posnick D, Dunbar S, Bloom B, Goldberg DJ. Energy based device treatment of melasma: an update and review of the literature. J Cosmet Laser Ther. 2017;19:2–12.CrossRefPubMedGoogle Scholar
  12. 12.
    Cohen PR. Melasma treatment: a novel approach using a topical agent that contains an anti-estrogen and a vascular endothelial growth factor inhibitor. Med Hypothese. 2017;101:1–5.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Department of DermatologyUniversity of California San DiegoLa JollaUSA
  2. 2.San DiegoUSA

Personalised recommendations